Impax Asset Management Group PLC Repligen Corp Transaction History

Impax Asset Management Group PLC

  • $23 Billion
  • Q3 2024

A detailed history of Impax Asset Management Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Impax Asset Management Group PLC holds 1,058,169 shares of RGEN stock, worth $144 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
1,058,169
Previous 1,126,878 6.1%
Holding current value
$144 Million
Previous $142 Million 10.86%
% of portfolio
0.69%
Previous 0.62%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$119.79 - $167.35 $8.23 Million - $11.5 Million
-68,709 Reduced 6.1%
1,058,169 $157 Million
Q2 2024

Aug 05, 2024
BUY
$120.0 - $182.95 $53.5 Million - $81.6 Million
445,858 Added 65.47%
1,126,878 $142 Million
Q1 2024

Apr 30, 2024
SELL
$170.78 - $208.42 $39.6 Million - $48.3 Million
-231,801 Reduced 25.39%
681,020 $125 Million
Q4 2023

Jan 26, 2024
SELL
$114.17 - $185.35 $6.83 Million - $11.1 Million
-59,848 Reduced 6.15%
912,821 $164 Million
Q3 2023

Nov 07, 2023
SELL
$138.78 - $176.51 $5.47 Million - $6.95 Million
-39,398 Reduced 3.89%
972,669 $155 Million
Q2 2023

Aug 07, 2023
BUY
$138.42 - $180.31 $20.2 Million - $26.3 Million
145,688 Added 16.82%
1,012,067 $143 Million
Q1 2023

May 10, 2023
BUY
$154.26 - $198.1 $7.02 Million - $9.02 Million
45,527 Added 5.55%
866,379 $146 Million
Q4 2022

Feb 09, 2023
BUY
$162.42 - $220.56 $10.8 Million - $14.7 Million
66,751 Added 8.85%
820,852 $139 Million
Q3 2022

Nov 08, 2022
SELL
$160.42 - $256.21 $15.4 Million - $24.6 Million
-96,050 Reduced 11.3%
754,101 $140 Million
Q2 2022

Aug 11, 2022
SELL
$140.68 - $188.02 $6.07 Million - $8.11 Million
-43,160 Reduced 4.83%
850,151 $137 Million
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $12.9 Million - $20.7 Million
80,299 Added 9.88%
893,311 $167 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $48.4 Million - $59.5 Million
195,300 Added 31.62%
813,012 $214 Million
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $38.7 Million - $64.5 Million
-198,804 Reduced 24.35%
617,712 $178 Million
Q2 2021

Aug 05, 2021
BUY
$165.87 - $220.95 $8.35 Million - $11.1 Million
50,362 Added 6.57%
816,516 $162 Million
Q1 2021

May 14, 2021
BUY
$180.37 - $226.26 $37 Million - $46.5 Million
205,306 Added 36.61%
766,154 $148 Million
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $40.8 Million - $57 Million
275,711 Added 96.69%
560,848 $107 Million
Q3 2020

Nov 12, 2020
SELL
$122.51 - $158.27 $423,762 - $547,455
-3,459 Reduced 1.2%
285,137 $41.6 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $11.8 Million - $17.6 Million
125,496 Added 76.94%
288,596 $35.7 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $13.9 Million - $17.8 Million
163,100 New
163,100 $15.6 Million

Others Institutions Holding RGEN

# of Institutions
490
Shares Held
53.8M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.57B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email